SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-075283
Filing Date
2015-11-03
Accepted
2015-11-03 16:04:03
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17830_110q.htm 10-Q 685711
2 EX-31.1 a15-17830_1ex31d1.htm EX-31.1 9600
3 EX-31.2 a15-17830_1ex31d2.htm EX-31.2 9617
4 EX-32.1 a15-17830_1ex32d1.htm EX-32.1 5231
5 EX-32.2 a15-17830_1ex32d2.htm EX-32.2 5235
  Complete submission text file 0001104659-15-075283.txt   2914808

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fate-20150930.xml EX-101.INS 448520
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20150930.xsd EX-101.SCH 31209
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fate-20150930_cal.xml EX-101.CAL 36629
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fate-20150930_def.xml EX-101.DEF 97245
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fate-20150930_lab.xml EX-101.LAB 306132
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20150930_pre.xml EX-101.PRE 187110
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 151193683
SIC: 2836 Biological Products, (No Diagnostic Substances)